-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
"This year, we have seen a lot of uncertainty brought about by the new crown epidemic, but we have also seen the strong resilience of the market, which has strengthened our confidence in expanding development in China
.
Recently, multinational chemical giants such as LANXESS, BASF, Huntsman, and Evonik that have invested in Shanghai have successively released their 2019 financial reports
.
Judging from the financial report figures of various companies, affected by the global economic situation, chemical companies have encountered considerable operating pressure in 2019
.
Some chemical companies said that the outbreak of the new crown pneumonia at the beginning of this year is expected to bring greater challenges to the development of chemical companies
.
Ke Diwen, President and Chairman of BASF Greater China, said: "The Chinese government and the Shanghai government have taken decisive and strong measures to control the spread of the new crown virus, and we fully support this
.
It is reported that BASF, Huntsman, LANXESS, Evonik and other production bases and construction projects in Shanghai have resumed production
.
Therefore, chemical giants have pointed out that the Asia-Pacific market led by China is a new opportunity for enterprise development after releasing their financial reports
.
Qian Mingcheng revealed that in 2019, LANXESS Greater China achieved double-digit growth
.
Over the next five years, BASF plans to spend 23.
6 billion euros in capital expenditure, more than a third of which will be allocated between 2020 and 2024 to key growth areas, namely two in Asia, said Brudermüller, Chairman of the Executive Board of BASF Europe Large-scale projects - integrated base in Guangdong, China, chemical industry cluster in Mundra, India
.
He said: "Our investment focus will shift regionally
.
In the next five years, we will allocate 41% of our investment to the Asia-Pacific region and 34% of our investment to Europe
.
" Ke Diwen also said that since 1885, BASF is China's partner.
"Currently, China is BASF's third largest market in the world after Germany and the United States, and it is also the main growth market for BASF's business development
.
We maintain confidence in China's long-term economic development
.
"
Pan Lumin also said that China is already Huntsman's second largest market in the world.
In 2019, Huntsman Group's Asia-Pacific regional headquarters officially settled in Shanghai.
This series of major events has confirmed Huntsman's determination and confidence to develop based on China
.
"In the long run, Huntsman's confidence in continuing to deepen investment in China has never changed
.
" He revealed that in Shanghai, Huntsman's Caojing modified MDI (diphenylmethane diisocyanate) plant is expected to expand production this year.
Done
.
After the project is completed, the annual production capacity can be increased by 60%, which can better support the downstream extension of the polyurethane business
.
Chen Jinqiu, general manager of Evonik Specialty Chemicals (Shanghai) Co.
, Ltd.
, said that Evonik has been developing in China for decades and has long been closely linked with China
.
The epidemic has made 2020 different, but it will not shake Evonik's determination to develop in China.
"This year, we have several investment projects in China, including projects under construction in the Shanghai Chemical Industry Park
.
These projects will be progressing normally
.
We believe that China will defeat the new crown virus at an early date and jointly build a safe, healthy and better future
.
"
